Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity
Eun Jae Park, Hye Won Jun, Ik Ho Na, et al.
Archives of Pharmacal Research (2021) Vol. 45, Iss. 1, pp. 1-10
Closed Access | Times Cited: 20

Showing 20 citing articles:

Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
Jialei Weng, Zheng Wang, Zhiqiu Hu, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1817-1833
Closed Access | Times Cited: 10
Implications of inflammatory cell death-PANoptosis in health and disease
Hyun W. Bae, Y.H. Jang, Rajendra Karki, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 7, pp. 617-631
Closed Access | Times Cited: 4
SLAM family-mediated crosstalk between tumor and immune cells in the tumor microenvironment: a promising biomarker and a potential therapeutic target for immune checkpoint therapies
Louis Boafo Kwantwi
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 901-908
Closed Access | Times Cited: 4
Identification of prognostic biomarker of non-small cell lung cancer based on mitochondrial permeability transition-driven necrosis-related genes and determination of anti-tumor effect of ARL14
Zhifei Ma, Wen Chen, Aiping Zhang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients
Wei Li, Huaman Wu, Juan Xu
Cancer Genetics (2023) Vol. 278-279, pp. 24-37
Closed Access | Times Cited: 9
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes
Chang‐Keun Cho, Hye-Jung Park, Pureum Kang, et al.
Archives of Pharmacal Research (2021) Vol. 44, Iss. 12, pp. 1076-1090
Closed Access | Times Cited: 22
Effects of PEG-Linker Chain Length of Folate-Linked Liposomal Formulations on Targeting Ability and Antitumor Activity of Encapsulated Drug
Chaemin Lim, Yuseon Shin, Kioh Kang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1615-1630
Open Access | Times Cited: 8
The role of CCL2, CCL7, ICAM-1, and VCAM-1 in interaction of endothelial cells and natural killer cells
Hye Won Jun, Hong Kyung Lee, Ik Ho Na, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109332-109332
Closed Access | Times Cited: 13
Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors
Metin Gunes, Steven T. Rosen, Idit Shachar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Combined Photothermal/Combination Chemotherapeutic Approach Using Zif-8-Supported Artesunate and Gold Nanorods
Xing Li, Jun Wang, Wanzhen Li, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 10, pp. 11587-11598
Closed Access | Times Cited: 2
FHL1 As a Novel Prognostic Biomarker and Correlation with Immune Infiltration Levels in Lung Adenocarcinoma
Jingtao Zhang, Haitao Li, Minghao Guo, et al.
Immunotherapy (2023) Vol. 15, Iss. 4, pp. 235-252
Open Access | Times Cited: 5
Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma
Ganghua Zhang, Zhijing Yin, Jianing Fang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Faslpr mice
Hyung Sook Kim, Hong Kyung Lee, Kihyeon Kim, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
A Systematic Immune and Prognostic Analysis of CD48 Interaction with Tumor Microenvironment in Pan-Cancer
Mingdong He, Jun Yu, Shaohua Chen, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 5255-5269
Open Access | Times Cited: 2
Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identifying Prognostic Hub Genes and Key Pathways in Pediatric Adrenocortical Tumors through RNA Sequencing and Co-expression Analysis.
Luciana Chain Veronez, Alcides Euzebio Tavares Xavier, Luís Fernando Peinado Nagano, et al.
Molecular and Cellular Endocrinology (2024), pp. 112383-112383
Closed Access
DriverMP enables improved identification of cancer driver genes
Yangyang Liu, Jiyun Han, Tongxin Kong, et al.
GigaScience (2022) Vol. 12
Open Access | Times Cited: 1
Construction of the Novel Immune Risk Scoring System Related to CD8 + T Cells in Uterine Corpus Endometrial Carcinoma
Ganghua Zhang, Zhijing Yin, Jianing Fang, et al.
Research Square (Research Square) (2023)
Open Access
Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST
Rebecca Kotzur, Natan Stein, Shira Kahlon, et al.
iScience (2023) Vol. 26, Iss. 8, pp. 107284-107284
Open Access
Identification and characterization of isoform-specific antibodies to human CD48
Zhenpeng Xi, Shanshan Wang, Q. Rong, et al.
JUSTC (2022) Vol. 52, pp. 1-1
Closed Access
Page 1

Scroll to top